| The Protein Kinase Facts Book
| [0002]
|
| FASEB J.
| [0002]
|
| Science
| [0002]
|
| Cell
| [0002]
|
| Cell
| [0002]
|
| EMBO J.
| [0002]
|
| Nat Rev Immunol
| [0004]
|
| Trends Immunol.
| [0005]
|
| DDT
| [0008]
|
| J Allergy Clin Immunol.
| [0008]
|
| Blood
| [0008]
|
| Blood
| [0008]
|
| Immunol. Rev.
| [0009]
|
| Blood
| [0009]
|
| Nat Rev Immunol
| [0009]
|
| Blood
| [0009]
|
| EMBO J.
| [0009]
|
| J. Exp. Med.
| [0014]
|
| J. E. Med.
| [0015]
|
| J. Biol. Chem.
| [0016]
|
| EMBO J.
| [0016]
|
| Proc. Natl. Acad. Sci. USA
| [0017]
|
| Mol. Cell. Biol.
| [0017]
|
| Mol Cell Biol.
| [0017]
|
| Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition)
| [0018]
|
| Br. J. Haematol
| [0018]
|
| Blood
| [0018]
|
| Blood
| [0019]
[0021]
|
| Constitutive activation of the protein tyrosine kinase Syk in Chronic Lymphocytic Leukemia B-cells
| [0019]
|
| Blood
| [0019]
[0024]
|
| Br. J. Haematol.
| [0020]
|
| Blood
| [0020]
|
| JEM
| [0020]
[0020]
|
| Cell
| [0021]
|
| Cell
| [0021]
|
| Nat Rev Cancer
| [0021]
|
| Annu Rev Immunol
| [0022]
|
| Mol Cell
| [0022]
|
| Nature
| [0022]
|
| Cell
| [0022]
|
| Cell
| [0022]
|
| Blood
| [0022]
|
| J Immunol
| [0022]
|
| Br J Haematol
| [0023]
|
| Blood
| [0023]
|
| J Exp Med
| [0023]
|
| Blood
| [0023]
|
| J Immunol
| [0023]
|
| J Pharmacol Exp Ther
| [0024]
|
| Hematology Am Soc Hematol Educ Program
| [0024]
|
| Blood
| [0024]
|
| Blood
| [0024]
|
| Blood
| [0025]
|
| Blood
| [0025]
|
| Brit J. Haematology
| [0025]
|
| J. Immunol
| [0025]
|
| Blood
| [0025]
|
| Z Rheumatol
| [0026]
|
| Distinct roles for Dectin-1 and TLR4 in the pathogenesis of Aspergillus fumigatus keratitis
| [0027]
|
| C-type lectin receptor-induced NF-κB activation in innate immune and inflammatory responses
| [0028]
|
| The role of Syk/CARD9 coupled C-type lectins in antifungal immunity
| [0028]
|
| Mycobacterium abscessus activates the NLRP3 inflammasome via Dectin-1-Syk and p62/SQSTM1
| [0028]
|
| Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
| [0030]
|
| LRRK2 in Parkinson's disease: protein domains and functional insights
| [0030]
|
| LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?
| [0030]
|
| LRRK2 mutations in Parkinson disease
| [0030]
|
| A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations
| [0030]
|
| The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers
| [0030]
|
| LRRK2 variant associated with Alzheimer's disease
| [0030]
|
| LRRK2 and Human Disease: A Complicated Question or a Question of Complexes?
| [0030]
|
| The role of LRRK2 in inflammatory bowel disease'', Cell research; ''LRRK2 as a negative regulator of NFAT: implications for the pathogenesis of inflammatory bowel disease'' Puja Vora, Dermot PB McGovern
| [0031]
|
| Development of a novel bioavailable inhibitor of the calmodulin-regulated protein kinase MLCK: a lead compound that attenuates vascular leak
| [0033]
|
| unpublished observations; Bratcher J M and Korelitz B I (2006) Toxicity of infliximab in the course of Crohn's disease
| [0033]
|
| A porous defense: the leaky epithelial barrier in intestinal disease
| [0033]
|
| Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo
| [0033]
|
| The burn edema process: current concepts
| [0033]
|
| Ventilator-induced lung injury: lessons from experimental studies
| [0033]
|
| Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise
| [0033]
|
| Myosin light chain kinase-dependent microvascular hyperpermeability in thermal injury
| [0033]
|
| Myosin light chain kinase inhibitors can block invasion and adhesion of human pancreatic cancer cell lines
| [0033]
|
| Mechanism of TNFalpha modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression
| [0033]
|
| Increased expression of myosin light chain kinase mRNA is related to metastasis in non-small cell lung cancer
| [0033]
|
| Protection against endotoxic shock as a consequence of reduced nitrosative stress in MLCK210-null mice
| [0033]
|
| A role for long chain myosin light chain kinase (MLCK-210) in microvascular hyperpermeability during severe burns
| [0033]
|
| Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial.
| [0033]
|
| Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase-dependent fashion
| [0033]
|
| Dependence of metastatic cancer cell invasion on MLCK-catalyzed phosphorylation of myosin regulatory light chain
| [0033]
|
| Protein kinase signaling in the modulation of microvascular permeability
| [0033]
|
| Myosin light chain phosphorylation in neutrophil-stimulated coronary microvascular leakage
| [0033]
|
| A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease
| [0033]
|
| Role of myosin light chain kinase in regulation of basal blood pressure and maintenance of salt-induced hypertension
| [0033]
|
| Protecting Groups
| [0097]
|
| Protective Groups in Organic Synthesis
| [0097]
|
| Biochem. Pharmacol.
| [0113]
|
| A Simple Kinetic Method for Rapid Mechanistic Analysis of Reversible Enzyme Inhibitors
| [0114]
|
| Leuk Res.
| [0119]
|